Rohto Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 7.92% vs 0.40% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 84.77% vs -52.54% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "88,814.00",
          "val2": "82,293.00",
          "chgp": "7.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18,737.00",
          "val2": "11,494.00",
          "chgp": "63.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "311.00",
          "val2": "286.00",
          "chgp": "8.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-24.00",
          "val2": "-9.00",
          "chgp": "-166.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10,569.00",
          "val2": "5,720.00",
          "chgp": "84.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "158.80%",
          "val2": "91.20%",
          "chgp": "6.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 13.95% vs 13.48% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -1.41% vs 18.79% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "308,625.00",
          "val2": "270,840.00",
          "chgp": "13.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "51,608.00",
          "val2": "48,854.00",
          "chgp": "5.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "949.00",
          "val2": "196.00",
          "chgp": "384.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2,068.00",
          "val2": "-916.00",
          "chgp": "-125.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30,951.00",
          "val2": "31,394.00",
          "chgp": "-1.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "124.60%",
          "val2": "148.30%",
          "chgp": "-2.37%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

88,814.00

82,293.00

7.92%

Operating Profit (PBDIT) excl Other Income

18,737.00

11,494.00

63.02%

Interest

311.00

286.00

8.74%

Exceptional Items

-24.00

-9.00

-166.67%

Consolidate Net Profit

10,569.00

5,720.00

84.77%

Operating Profit Margin (Excl OI)

158.80%

91.20%

6.76%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 7.92% vs 0.40% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 84.77% vs -52.54% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

308,625.00

270,840.00

13.95%

Operating Profit (PBDIT) excl Other Income

51,608.00

48,854.00

5.64%

Interest

949.00

196.00

384.18%

Exceptional Items

-2,068.00

-916.00

-125.76%

Consolidate Net Profit

30,951.00

31,394.00

-1.41%

Operating Profit Margin (Excl OI)

124.60%

148.30%

-2.37%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 13.95% vs 13.48% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -1.41% vs 18.79% in Mar 2024

All Annual Results